Please login to the form below

Not currently logged in
Email:
Password:

Chiltern appoints Roger Hunter to partnerships role

He will be tasked with developing long-term strategic partnerships

Chiltern Roger HunterUK-headquartered contract research organisation (CRO) has appointed Roger Hunter as vice president of strategic partnerships within its business development team.

He brings 25 years of pharma and biotech experience to the company and his most recent industry-side role was as VP of operations for a speciality pharmaceutical company.

Chiltern's VP of global business development Stuart McGuire said: “It gives me great pleasure to welcome Roger Hunter as Chiltern's new VP of strategic partnerships. Roger comes to us with a strong background in both commercial and development functions within pharma and biotech. He has a strong understanding of clinical development and a deep appreciation of the impact that we have on our clients.”

Roger Hunter added: “I look forward to working in close collaboration with our sponsors to develop long standing strategic partnerships with them through the delivery of innovative, quality and flexible solutions that address their key needs.” 

16th January 2013

From: Research

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
M3 (EU)

M3 has over 20 years’ experience in building online doctor communities. M3 is the world’s largest network of verified doctors...

Latest intelligence

Tree
Pharma’s vital role in sustainability and corporate social responsibility
Pharma is in the spotlight as tough questions about sustainability commitments continue to arise...
Infographic: Therapy Watch Hyperlipidaemia
Our latest infographic offers an introduction to the real-world insights collected by our Hyperlipidaemia study....
Article: The rise of the healthcare influencer
In our latest article for Pharmaphorum Deep Dive, we explore the opportunities and benefits for healthcare companies in the online influencer space....